LAS VEGAS, Nev.--(BUSINESS WIRE)--During the scientific sessions at the 16 th Annual NANS Conference, Dr. Liong Liem, Anesthesiologist at Sint Antonius Ziekenhuis in the Netherlands and member of the ...

Proceeds to support manufacturing growth, regulatory advancement, and disciplined commercialization expansion ExaStim® Stimulation System Pictured is the complete ExaStim® Stimulation System. Los ...

Please provide your email address to receive an email when new articles are posted on . The WaveWriter is approved to treat low back and leg pain in patients without prior back surgery. The system ...

Spinal cord stimulators have been used since the 1960s, and the first FDA approval for one of the devices arrived in 1989—all with a focus on treating various forms of chronic pain. In more recent ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Prospera, a spinal cord stimulation system to treat those with chronic intractable pain in ...

After racking up more than 30 years’ worth of experience in treating chronic pain, spinal cord stimulators have recently begun to expand their remit. Even as the devices continue to tack on new ...

Abbott's new Proclaim™ Plus spinal cord stimulation (SCS) system offers the next generation of stimulation therapy, giving physicians the ability to treat multi-site and evolving pain The system ...

The new indication for Abbott's Proclaim™ XR SCS system provides a non-medication option for people with painful diabetic peripheral neuropathy Spinal cord stimulation is proven to be more effective ...

Protégé upgradeable neurostimulator from St. Jude Medical is the world’s smallest, longest-lasting rechargeable device to treat chronic pain SCS system is designed to be non-invasively upgraded to ...

The FDA has approved Nevro Corp's (NYSE: NVRO) Senza system for treating chronic pain associated with painful diabetic neuropathy (PDN). The approval is specific to Nevro's 10 kHz stimulation. The ...

Nevro yesterday announced that the FDA has granted approval for a study evaluating its high-frequency spinal cord stimulation system for the treatment of chronic pain. The device company’s Senza ...

A nerve stimulation therapy developed at Columbia University Vagelos College of Physicians and Surgeons is showing promise in animal studies and may eventually allow people with spinal cord injuries ...